Table 4 Trends in treatment type, referral rates, and PERT usage changes pre- and post-operatively. Data are presented as the total number of symptomatic patients (n) and the percentage they represent (%), note the denominator of the percentage is the total number of symptomatic patients (N=36) and not the entire study cohort
Treatment | Symptomatic patients receiving treatment (%), n=365 |
|---|---|
PERT | 176 (48%) |
Proton Pump Inhibitor | 132 (36%) |
Cathartic | 115 (31%) |
Anti-emetic | 90 (25%) |
Appetite Stimulant | 12 (3%) |
Antibiotic | 6 (1.5%) |
Referral Rates | |
 GI Referral | 105 (29%) |
 Nutrition Referral | 12 (3%) |
PERT Usage among Symptomatic Patients | |
 Never used PERT | 182 (50%) |
 Initiated PERT following Surgery | 148 (40%) |
 Previously used PERT; continued Post-Op | 28 (8%) |
 Pre-op PERT; no Post-op PERT | 8 (2%) |